(Q46971184)

English

Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.

scientific article published on 20 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

0 references

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Nand Kishore Gupta

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Priti Tomar

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Vikas Sharma

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

0 references

publication date

20 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

48

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

9026-9037

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Current and future antiviral therapy of severe seasonal and avian influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

H1N1 2009 influenza virus infection during pregnancy in the USA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Neuraminidase inhibitors for influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Prevention and treatment of influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

The annual production cycle for influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Chitosan as a novel nasal delivery system for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

The biopharmaceutical aspects of nasal mucoadhesive drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

New strategies for using mucosal vaccination to achieve more effective immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Evaluation of the clearance characteristics of bioadhesive systems in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Nasal drug delivery--possibilities, problems and solutions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

The performance of nanocarriers for transmucosal drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Exploiting M cells for drug and vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Chitosan and the mucosal delivery of biotechnology drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Chitosan microspheres as a potential carrier for drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Preparation and characterization of chitosan and trimethyl-chitosan-modified poly-(epsilon-caprolactone) nanoparticles as DNA carriers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze-drying

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

A sensitive ELISPOT assay to detect low-frequency human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

A novel bioadhesive intranasal delivery system for inactivated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Preparation and purification of cationic solid lipid nanospheres--effects on particle size, physical stability and cell toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Aspects of the design and delivery of microparticles for vaccine applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Effects of different N-trimethyl chitosans on in vitro/in vivo ofloxacin transcorneal permeation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

IgG2a restriction of murine antibodies elicited by viral infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

The IgG subclass responses to influenza virus haemagglutinin in the mouse: effect of route of inoculation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Host defense mechanisms at mucosal surfaces

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

NALT- versus Peyer's-patch-mediated mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Bronchus- and nasal-associated lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.09.033

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.09.033

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21939718%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46971184&oldid=1369010529"